Precision Medicine for NSCLC in the Era of Immunotherapy: New Biomarkers to Select the Most Suitable Treatment or the Most Suitable Patient
2020-01-01 Rossi, G; Russo, A; Tagliamento, M; Tuzi, A; Nigro, O; Vallome, G; Sini, C; Grassi, M; Dal Bello, Mg; Coco, S; Longo, L; Zullo, L; Tanda, Et; Dellepiane, C; Pronzato, P; Genova, C.
Extracellular vesicle PD-L1 dynamics predict durable response to immune-checkpoint inhibitors and survival in patients with non-small cell lung cancer
2022-01-01 de Miguel-Perez, D; Russo, A; Arrieta, O; Ak, M; Barron, F; Gunasekaran, M; Mamindla, P; Lara-Mejia, L; Peterson, Cb; Er, Me; Peddagangireddy, V; Buemi, F; Cooper, B; Manca, P; Lapidus, Rg; Hsia, Rc; Cardona, Af; Naing, A; Kaushal, S; Hirsch, Fr; Mack, Pc; Serrano, Mj; Adamo, V; Colen, Rr; Rolfo, C.
Genomic profiling of tissue and blood predicts survival outcomes in patients with resected pleural mesothelioma.
2024-01-01 de Miguel-Perez, D; Pickering, Em; Malapelle, U; Grier, W; Pepe, F; Pisapia, P; Russo, G; Pinto, Ja; Russo, A; Troncone, G; Culligan, Mj; Scilla, Ka; Mehra, R; Mohindra, P; Arrieta, O; Cardona, Af; Del Re, M; Sachdeva, A; Hirsch, Fr; Wolf, A; Friedberg, Js; Rolfo, C.
Genomic Landscape of Primary Resistance to Osimertinib Among Hispanic Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC): Results of an Observational Longitudinal Cohort Study.
2023-01-01 Chamorro, Df; Cardona, Af; Rodríguez, J; Ruiz-Patiño, A; Arrieta, O; Moreno-Pérez, Da; Rojas, L; Zatarain-Barrón, Zl; Ardila, Dv; Viola, L; Recondo, G; Blaquier, Jb; Martín, C; Raez, L; Samtani, S; Ordóñez-Reyes, C; Garcia-Robledo, Je; Corrales, L; Sotelo, C; Ricaurte, L; Cuello, M; Mejía, S; Jaller, E; Vargas, C; Carranza, H; Otero, J; Archila, P; Bermudez, M; Gamez, T; Russo, A; Malapelle, U; De Miguel Perez, D; De Lima, Vcc; Freitas, H; Saldahna, E; Rolfo, C; Rosell, R; Clica, P.
Effect of concomitant medications with immune-modulatory properties on the outcomes of patients with advanced cancer treated with immune checkpoint inhibitors: development and validation of a novel prognostic index.
2021-01-01 Buti, S; Bersanelli, M; Perrone, F; Tiseo, M; Tucci, M; Adamo, V; Stucci, Ls; Russo, A; Tanda, Et; Spagnolo, F; Rastelli, F; Pergolesi, F; Santini, D; Russano, M; Anesi, C; Giusti, R; Filetti, M; Marchetti, P; Botticelli, A; Gelibter, A; Occhipinti, Ma; Ferrari, M; Vitale, Mg; Nicolardi, L; Chiari, R; Rijavec, E; Nigro, O; Tuzi, A; De Tursi, M; Di Marino, P; Conforti, F; Queirolo, P; Bracarda, S; Macrini, S; Gori, S; Zoratto, F; Veltri, E; Di Cocco, B; Mallardo, D; Vitale, Mg; Santoni, M; Patruno, L; Porzio, G; Ficorella, C; Pinato, Dj; Ascierto, Pa; Cortellini, A
Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice.
2020-01-01 Cortellini, A; Tucci, M; Adamo, V; Stucci, Ls; Russo, A; Tanda, Et; Spagnolo, F; Rastelli, F; Bisonni, R; Santini, D; Russano, M; Anesi, C; Giusti, R; Filetti, M; Marchetti, P; Botticelli, A; Gelibter, A; Occhipinti, Ma; Marconcini, R; Vitale, Mg; Nicolardi, L; Chiari, R; Bareggi, C; Nigro, O; Tuzi, A; De Tursi, M; Petragnani, N; Pala, L; Bracarda, S; Macrini, S; Inno, A; Zoratto, F; Veltri, E; Di Cocco, B; Mallardo, D; Vitale, Mg; Pinato, Dj; Porzio, G; Ficorella, C; Ascierto, Pa.
Liquid biopsy tracking of lung tumor evolutions over time
2019-01-01 Russo, A.; De Miguel Perez, D.; Gunasekaran, M.; Scilla, K.; Lapidus, R.; Cooper, B.; Mehra, R.; Adamo, V.; Malapelle, U.; Rolfo, C.
Efficacy of T-DM1 for leptomeningeal and brain metastases in a HER2 positive metastatic breast cancer patient: New directions for systemic therapy - a case report and literature review
2018-01-01 Ricciardi, Giuseppina Rosaria Rita; Russo, Alessandro; Franchina, Tindara; Schifano, Silvia; Mastroeni, Giampiero; Santacaterina, Anna; Adamo, Vincenzo
PD-1/PD-L1 checkpoint inhibitors during late stages of life: an ad-hoc analysis from a large multicenter cohort.
2021-01-01 Santini, D; Zeppola, T; Russano, M; Citarella, F; Anesi, C; Buti, S; Tucci, M; Russo, A; Sergi, Mc; Adamo, V; Stucci, Ls; Bersanelli, M; Mazzaschi, G; Spagnolo, F; Rastelli, F; Giorgi, Fc; Giusti, R; Filetti, M; Marchetti, P; Botticelli, A; Gelibter, A; Siringo, M; Ferrari, M; Marconcini, R; Vitale, Mg; Nicolardi, L; Chiari, R; Ghidini, M; Nigro, O; Grossi, F; De Tursi, M; Di Marino, P; Pala, L; Queirolo, P; Bracarda, S; Macrini, S; Gori, S; Inno, A; Zoratto, F; Tanda, Et; Mallardo, D; Vitale, Mg; Talbot, T; Ascierto, Pa; Pinato, Dj; Ficorella, C; Porzio, G; Cortellini, A.
Expanding the Full Potential of Liquid Biopsies for Lung Cancer Patients
2022-01-01 Rolfo, C; Malapelle, U; Russo, A
Tracking clonal evolution of EGFR-mutated non-small cell lung cancer through liquid biopsy: Management of C797S acquired mutation
2023-01-01 Russo, A; Scilla, Ka; Mehra, R; Gittens, A; Mccusker, Mg; de Miguel-Perez, D; Gomez, Je; Peleg, A; Del Re, M; Rolfo, Cd.
Central nervous system involvement in ALK-rearranged NSCLC: promising strategies to overcome crizotinib resistance
2016-01-01 Russo, Alessandro; Franchina, Tindara; Ricciardi, Giuseppina Rosaria Rita; Ferraro, Giuseppa; Scimone, Antonino; Bronte, Giuseppe; Russo, Antonio; Rolfo, Christian; Adamo, Vincenzo
Mechanisms of Resistance to first-line Osimertinib in Hispanic patients with EGFR mutant non-small cell lung cancer (FRESTON-CLICaP).
2022-01-01 Cardona, Af; Ruiz-Patiño, A; Recondo, G; Martín, C; Raez, L; Samtani, S; Minata, Jn; Blaquier, Jb; Enrico, D; Burotto, M; Ordóñez-Reyes, C; Chamorro, Df; Garcia-Robledo, Je; Corrales, L; Zatarain-Barrón, Zl; Más, L; Sotelo, C; Ricaurte, L; Santoyo, N; Cuello, M; Mejía, S; Jaller, E; Vargas, C; Carranza, H; Otero, J; Rodríguez, J; Archila, P; Bermudez, M; Gamez, T; De Lima, Vc; Freitas, H; Russo, A; Polo, C; Malapelle, U; Perez, D De M; Rolfo, C; Viola, L; Rosell, R; Arrieta, O
Sotorasib in KRASp.G12C mutated advanced NSCLC: Real-word data from the Italian Expanded Access Program
2024-01-01 Passiglia, F; Reale, Ml; Lo Russo, G; Pasello, G; Minuti, G; Bulotta, A; Galetta, D; Pelizzari, G; Sini, C; Bria, E; Roca, E; Pilotto, S; Genova, C; Metro, G; Citarella, F; Chiari, R; Cortinovis, D; Delmonte, A; Russo, A; Tiseo, M; Cerea, G; Carta, A; Scotti, V; Vavalà, T; Brambilla, M; Buffoni, L; Buosi, R; Catania, C; Gori, S; Grisanti, S; Agustoni, F; Garbo, E; Malapelle, U; Novello, S
Skipping or Not Skipping? That's the Question! An Algorithm to Classify Novel MET Exon 14 Variants in Non-Small-Cell Lung Cancer
2023-01-01 Rolfo, C; Malapelle, U; Russo, A
Next Generation Sequencing for liquid biopsy based testing in Non-Small Cell Lung Cancer in 2021
2021-01-01 Pisapia, P; Costa, Jl; Pepe, F; Russo, G; Gragnano, G; Russo, A; Iaccarino, A; de Miguel-Perez, D; Serrano, Mj; Denninghoff, V; Quagliata, L; Rolfo, C; Malapelle, U.
Tolvaptan resistance is related with a short-term poor prognosis in patients with lung cancer and syndrome of inappropriate anti-diuresis
2023-01-01 Lacquaniti, A; Campo, S; Russo, A; Adamo, V; Monardo, P.
Liquid Biopsy in Lung Cancer Screening: The Contribution of Metabolomics. Results of A Pilot Study
2019-01-01 Singhal, Sandeep; Rolfo, Christian; Maksymiuk, Andrew W; Tappia, Paramjit S; Sitar, Daniel S; Russo, Alessandro; Akhtar, Parveen S; Khatun, Nazrina; Rahnuma, Parveen; Rashiduzzaman, Ahmed; Ahmed Bux, Rashid; Huang, Guoyu; Ramjiawan, Bram
NSCLC and HER2: between lights and shadows
2014-01-01 Ricciardi, Giuseppina Rosaria Rita; Russo, Alessandro; Franchina, Tindara; Ferraro, Giuseppa; Zanghi', Mariangela; Picone, Antonio; Scimone, Antonino; Adamo, Vincenzo
Emerging role of Radium-223 in the growing therapeutic armamentarium of metastatic castration-resistant prostate cancer
2017-01-01 Picciotto, Maria; Franchina, Tindara; Russo, Alessandro; Ricciardi, Giuseppina Rosaria Rita; Provazza, Giusy; Sava, Serena; Baldari, Sergio; Caffo, Orazio; Adamo, Vincenzo
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Precision Medicine for NSCLC in the Era of Immunotherapy: New Biomarkers to Select the Most Suitable Treatment or the Most Suitable Patient | 1-gen-2020 | Rossi, G; Russo, A; Tagliamento, M; Tuzi, A; Nigro, O; Vallome, G; Sini, C; Grassi, M; Dal Bello, Mg; Coco, S; Longo, L; Zullo, L; Tanda, Et; Dellepiane, C; Pronzato, P; Genova, C. | |
| Extracellular vesicle PD-L1 dynamics predict durable response to immune-checkpoint inhibitors and survival in patients with non-small cell lung cancer | 1-gen-2022 | de Miguel-Perez, D; Russo, A; Arrieta, O; Ak, M; Barron, F; Gunasekaran, M; Mamindla, P; Lara-Mejia, L; Peterson, Cb; Er, Me; Peddagangireddy, V; Buemi, F; Cooper, B; Manca, P; Lapidus, Rg; Hsia, Rc; Cardona, Af; Naing, A; Kaushal, S; Hirsch, Fr; Mack, Pc; Serrano, Mj; Adamo, V; Colen, Rr; Rolfo, C. | |
| Genomic profiling of tissue and blood predicts survival outcomes in patients with resected pleural mesothelioma. | 1-gen-2024 | de Miguel-Perez, D; Pickering, Em; Malapelle, U; Grier, W; Pepe, F; Pisapia, P; Russo, G; Pinto, Ja; Russo, A; Troncone, G; Culligan, Mj; Scilla, Ka; Mehra, R; Mohindra, P; Arrieta, O; Cardona, Af; Del Re, M; Sachdeva, A; Hirsch, Fr; Wolf, A; Friedberg, Js; Rolfo, C. | |
| Genomic Landscape of Primary Resistance to Osimertinib Among Hispanic Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC): Results of an Observational Longitudinal Cohort Study. | 1-gen-2023 | Chamorro, Df; Cardona, Af; Rodríguez, J; Ruiz-Patiño, A; Arrieta, O; Moreno-Pérez, Da; Rojas, L; Zatarain-Barrón, Zl; Ardila, Dv; Viola, L; Recondo, G; Blaquier, Jb; Martín, C; Raez, L; Samtani, S; Ordóñez-Reyes, C; Garcia-Robledo, Je; Corrales, L; Sotelo, C; Ricaurte, L; Cuello, M; Mejía, S; Jaller, E; Vargas, C; Carranza, H; Otero, J; Archila, P; Bermudez, M; Gamez, T; Russo, A; Malapelle, U; De Miguel Perez, D; De Lima, Vcc; Freitas, H; Saldahna, E; Rolfo, C; Rosell, R; Clica, P. | |
| Effect of concomitant medications with immune-modulatory properties on the outcomes of patients with advanced cancer treated with immune checkpoint inhibitors: development and validation of a novel prognostic index. | 1-gen-2021 | Buti, S; Bersanelli, M; Perrone, F; Tiseo, M; Tucci, M; Adamo, V; Stucci, Ls; Russo, A; Tanda, Et; Spagnolo, F; Rastelli, F; Pergolesi, F; Santini, D; Russano, M; Anesi, C; Giusti, R; Filetti, M; Marchetti, P; Botticelli, A; Gelibter, A; Occhipinti, Ma; Ferrari, M; Vitale, Mg; Nicolardi, L; Chiari, R; Rijavec, E; Nigro, O; Tuzi, A; De Tursi, M; Di Marino, P; Conforti, F; Queirolo, P; Bracarda, S; Macrini, S; Gori, S; Zoratto, F; Veltri, E; Di Cocco, B; Mallardo, D; Vitale, Mg; Santoni, M; Patruno, L; Porzio, G; Ficorella, C; Pinato, Dj; Ascierto, Pa; Cortellini, A | |
| Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice. | 1-gen-2020 | Cortellini, A; Tucci, M; Adamo, V; Stucci, Ls; Russo, A; Tanda, Et; Spagnolo, F; Rastelli, F; Bisonni, R; Santini, D; Russano, M; Anesi, C; Giusti, R; Filetti, M; Marchetti, P; Botticelli, A; Gelibter, A; Occhipinti, Ma; Marconcini, R; Vitale, Mg; Nicolardi, L; Chiari, R; Bareggi, C; Nigro, O; Tuzi, A; De Tursi, M; Petragnani, N; Pala, L; Bracarda, S; Macrini, S; Inno, A; Zoratto, F; Veltri, E; Di Cocco, B; Mallardo, D; Vitale, Mg; Pinato, Dj; Porzio, G; Ficorella, C; Ascierto, Pa. | |
| Liquid biopsy tracking of lung tumor evolutions over time | 1-gen-2019 | Russo, A.; De Miguel Perez, D.; Gunasekaran, M.; Scilla, K.; Lapidus, R.; Cooper, B.; Mehra, R.; Adamo, V.; Malapelle, U.; Rolfo, C. | |
| Efficacy of T-DM1 for leptomeningeal and brain metastases in a HER2 positive metastatic breast cancer patient: New directions for systemic therapy - a case report and literature review | 1-gen-2018 | Ricciardi, Giuseppina Rosaria Rita; Russo, Alessandro; Franchina, Tindara; Schifano, Silvia; Mastroeni, Giampiero; Santacaterina, Anna; Adamo, Vincenzo | |
| PD-1/PD-L1 checkpoint inhibitors during late stages of life: an ad-hoc analysis from a large multicenter cohort. | 1-gen-2021 | Santini, D; Zeppola, T; Russano, M; Citarella, F; Anesi, C; Buti, S; Tucci, M; Russo, A; Sergi, Mc; Adamo, V; Stucci, Ls; Bersanelli, M; Mazzaschi, G; Spagnolo, F; Rastelli, F; Giorgi, Fc; Giusti, R; Filetti, M; Marchetti, P; Botticelli, A; Gelibter, A; Siringo, M; Ferrari, M; Marconcini, R; Vitale, Mg; Nicolardi, L; Chiari, R; Ghidini, M; Nigro, O; Grossi, F; De Tursi, M; Di Marino, P; Pala, L; Queirolo, P; Bracarda, S; Macrini, S; Gori, S; Inno, A; Zoratto, F; Tanda, Et; Mallardo, D; Vitale, Mg; Talbot, T; Ascierto, Pa; Pinato, Dj; Ficorella, C; Porzio, G; Cortellini, A. | |
| Expanding the Full Potential of Liquid Biopsies for Lung Cancer Patients | 1-gen-2022 | Rolfo, C; Malapelle, U; Russo, A | |
| Tracking clonal evolution of EGFR-mutated non-small cell lung cancer through liquid biopsy: Management of C797S acquired mutation | 1-gen-2023 | Russo, A; Scilla, Ka; Mehra, R; Gittens, A; Mccusker, Mg; de Miguel-Perez, D; Gomez, Je; Peleg, A; Del Re, M; Rolfo, Cd. | |
| Central nervous system involvement in ALK-rearranged NSCLC: promising strategies to overcome crizotinib resistance | 1-gen-2016 | Russo, Alessandro; Franchina, Tindara; Ricciardi, Giuseppina Rosaria Rita; Ferraro, Giuseppa; Scimone, Antonino; Bronte, Giuseppe; Russo, Antonio; Rolfo, Christian; Adamo, Vincenzo | |
| Mechanisms of Resistance to first-line Osimertinib in Hispanic patients with EGFR mutant non-small cell lung cancer (FRESTON-CLICaP). | 1-gen-2022 | Cardona, Af; Ruiz-Patiño, A; Recondo, G; Martín, C; Raez, L; Samtani, S; Minata, Jn; Blaquier, Jb; Enrico, D; Burotto, M; Ordóñez-Reyes, C; Chamorro, Df; Garcia-Robledo, Je; Corrales, L; Zatarain-Barrón, Zl; Más, L; Sotelo, C; Ricaurte, L; Santoyo, N; Cuello, M; Mejía, S; Jaller, E; Vargas, C; Carranza, H; Otero, J; Rodríguez, J; Archila, P; Bermudez, M; Gamez, T; De Lima, Vc; Freitas, H; Russo, A; Polo, C; Malapelle, U; Perez, D De M; Rolfo, C; Viola, L; Rosell, R; Arrieta, O | |
| Sotorasib in KRASp.G12C mutated advanced NSCLC: Real-word data from the Italian Expanded Access Program | 1-gen-2024 | Passiglia, F; Reale, Ml; Lo Russo, G; Pasello, G; Minuti, G; Bulotta, A; Galetta, D; Pelizzari, G; Sini, C; Bria, E; Roca, E; Pilotto, S; Genova, C; Metro, G; Citarella, F; Chiari, R; Cortinovis, D; Delmonte, A; Russo, A; Tiseo, M; Cerea, G; Carta, A; Scotti, V; Vavalà, T; Brambilla, M; Buffoni, L; Buosi, R; Catania, C; Gori, S; Grisanti, S; Agustoni, F; Garbo, E; Malapelle, U; Novello, S | |
| Skipping or Not Skipping? That's the Question! An Algorithm to Classify Novel MET Exon 14 Variants in Non-Small-Cell Lung Cancer | 1-gen-2023 | Rolfo, C; Malapelle, U; Russo, A | |
| Next Generation Sequencing for liquid biopsy based testing in Non-Small Cell Lung Cancer in 2021 | 1-gen-2021 | Pisapia, P; Costa, Jl; Pepe, F; Russo, G; Gragnano, G; Russo, A; Iaccarino, A; de Miguel-Perez, D; Serrano, Mj; Denninghoff, V; Quagliata, L; Rolfo, C; Malapelle, U. | |
| Tolvaptan resistance is related with a short-term poor prognosis in patients with lung cancer and syndrome of inappropriate anti-diuresis | 1-gen-2023 | Lacquaniti, A; Campo, S; Russo, A; Adamo, V; Monardo, P. | |
| Liquid Biopsy in Lung Cancer Screening: The Contribution of Metabolomics. Results of A Pilot Study | 1-gen-2019 | Singhal, Sandeep; Rolfo, Christian; Maksymiuk, Andrew W; Tappia, Paramjit S; Sitar, Daniel S; Russo, Alessandro; Akhtar, Parveen S; Khatun, Nazrina; Rahnuma, Parveen; Rashiduzzaman, Ahmed; Ahmed Bux, Rashid; Huang, Guoyu; Ramjiawan, Bram | |
| NSCLC and HER2: between lights and shadows | 1-gen-2014 | Ricciardi, Giuseppina Rosaria Rita; Russo, Alessandro; Franchina, Tindara; Ferraro, Giuseppa; Zanghi', Mariangela; Picone, Antonio; Scimone, Antonino; Adamo, Vincenzo | |
| Emerging role of Radium-223 in the growing therapeutic armamentarium of metastatic castration-resistant prostate cancer | 1-gen-2017 | Picciotto, Maria; Franchina, Tindara; Russo, Alessandro; Ricciardi, Giuseppina Rosaria Rita; Provazza, Giusy; Sava, Serena; Baldari, Sergio; Caffo, Orazio; Adamo, Vincenzo |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista27914
Data di pubblicazione
- In corso di stampa14
- 2020 - 20269649
- 2010 - 201911835
- 2000 - 20094579
- 1990 - 19991485
- 1980 - 1989329
- 1975 - 197923
Editore
- Edition AERCV1
- Elsevier1
- Futura Publishing Company1
- Grafica Luigi Monti s.r.l.1
- Karger, Basel1
- Mosby1
- sn1
- Springer-Verlag1
- Thieme1
Rivista
- DIGESTIVE AND LIVER DISEASE372
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...267
- ANNALS OF ONCOLOGY244
- CANCERS232
- PLOS ONE223
- THE JOURNAL OF NUCLEAR MEDICINE222
- JOURNAL OF CLINICAL MEDICINE215
- EUROPEAN JOURNAL OF CANCER205
- GASTROINTESTINAL ENDOSCOPY197
- ALLERGY180
Keyword
- Humans2166
- Female1035
- Male996
- Middle Aged767
- Aged669
- Adult559
- COVID-19442
- Treatment Outcome373
- Animals329
- Retrospective Studies264
Lingua
- eng19968
- ita459
- spa14
- fre11
- ger8
- enm4
- por2
- chi1
Accesso al fulltext
- no fulltext25661
- reserved1362
- open891